We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Autifony Awarded £2.2 Million to Progress AUT00063 for Tinnitus into Phase IIa Study

News   Jun 04, 2014

 
Autifony Awarded £2.2 Million to Progress AUT00063 for Tinnitus into Phase IIa Study
 
 
 

RELATED ARTICLES

5.1 Million Dollar Funding Boost for Blinding Retinal Conditions

News

A $5.1 million grant has been awarded from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.

READ MORE

Immunotherapy Success for Triple-Negative Breast Cancer

News

New research has shown that by using a combination of immunotherapy and chemotherapy the body’s own immune system can be tuned to attack triple-negative breast cancer, extending survival by up to ten months.

READ MORE

Curing Drug-Resistant Infections Without Antibiotics

News

Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE